Author

Rachel Smith

Primary ORCID profile (0000-0002-4665-7003 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Rachel SmithiD1 paper · University of Manchester

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alexander MuikiD· 1 shared Andrew P. McKeen· 1 shared Annaliesa S. AndersoniD· 1 shared Annette B. VogeliD· 1 shared Brittney Cumbia· 1 shared Carla I. Cadima· 1 shared Deanne M. Illenberger· 1 shared Frank Gillett· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alexander MuikORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivNov 17, 2023

Preclinical Characterization of the Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine

Kayvon Modjarrad, Ye Che, Wei Chen…·Kena A. Swanson

The monovalent Omicron XBB.1.5-adapted BNT162b2 mRNA vaccine elicits stronger neutralizing antibody responses against XBB.1.5 and related sublineages than the bivalent Wild Type + Omicron BA.4/5 vaccine.

DOI 10.1038/s41541-024-01013-9

mouseexperimental assay

𝕏 PostBluesky